Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/24376
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDriessen, J. H. M.-
dc.contributor.authorKnapen, L. M.-
dc.contributor.authorGEUSENS, Piet-
dc.contributor.authorVAN DEN BERGH, Joop-
dc.date.accessioned2017-09-06T10:45:19Z-
dc.date.available2017-09-06T10:45:19Z-
dc.date.issued2017-
dc.identifier.citationOSTEOPOROSIS INTERNATIONAL, 28(8), p. 2429-2430-
dc.identifier.issn0937-941X-
dc.identifier.urihttp://hdl.handle.net/1942/24376-
dc.language.isoen-
dc.publisherSPRINGER LONDON LTD-
dc.rights© International Osteoporosis Foundation and National Osteoporosis Foundation 201-
dc.titleFracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?-
dc.typeJournal Contribution-
dc.identifier.epage2430-
dc.identifier.issue8-
dc.identifier.spage2429-
dc.identifier.volume28-
local.format.pages2-
local.bibliographicCitation.jcatA1-
dc.description.notes[Driessen, J. H. M.; Knapen, L. M.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands. [Driessen, J. H. M.; van den Bergh, J. P. W.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands. [Driessen, J. H. M.; Knapen, L. M.] Maastricht Univ, Med Ctr, Dept Clin Pharm & Toxicol, Maastricht, Netherlands. [Driessen, J. H. M.] Utrecht Inst Pharmaceut Sci, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands. [Geusens, P. P. M. M.; van den Bergh, J. P. W.] Hasselt Univ, Biomed Res Ctr, Agoralaan Gebouw D, B-3590 Diepenbeek, Belgium. [Geusens, P. P. M. M.; van den Bergh, J. P. W.] Maastricht Univ, Med Ctr, Dept Internal Med, Subdivis Rheumatol,CAPHRI, Maastricht, Netherlands. [van den Bergh, J. P. W.] VieCuri Med Ctr, Dept Internal Med, POB 1926, NL-5900 BX Venlo, Netherlands.-
local.publisher.placeLONDON-
local.type.refereedRefereed-
local.type.specifiedLetter-
dc.identifier.doi10.1007/s00198-017-4120-2-
dc.identifier.isi000406275400020-
item.fulltextWith Fulltext-
item.accessRightsRestricted Access-
item.validationecoom 2018-
item.contributorDriessen, J. H. M.-
item.contributorKnapen, L. M.-
item.contributorGEUSENS, Piet-
item.contributorVAN DEN BERGH, Joop-
item.fullcitationDriessen, J. H. M.; Knapen, L. M.; GEUSENS, Piet & VAN DEN BERGH, Joop (2017) Fracture risk reduction with use of dipeptidyl peptidase-4 inhibitors: is there immortal time bias?. In: OSTEOPOROSIS INTERNATIONAL, 28(8), p. 2429-2430.-
crisitem.journal.issn0937-941X-
crisitem.journal.eissn1433-2965-
Appears in Collections:Research publications
Files in This Item:
File Description SizeFormat 
o.pdf
  Restricted Access		Published version276.51 kBAdobe PDFView/Open    Request a copy
Show simple item record

SCOPUSTM   
Citations

3
checked on Sep 3, 2020

WEB OF SCIENCETM
Citations

3
checked on May 8, 2024

Page view(s)

60
checked on Sep 5, 2022

Download(s)

42
checked on Sep 5, 2022

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.